Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Orkin

Showing results (11-20 of 331) with videos related to

Pageof 34
Sort By:
Genome Medicine|December 1, 2011
Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicineJonghwan Kim, Stuart H Orkin
Cell Stem Cell|January 9, 2009
Glimpses of the epigenetic landscapeXiaohua Shen, Stuart H Orkin
Science (New York, N.Y.)|May 28, 2016
MEDICINE. Paying for future success in gene therapyStuart H Orkin, Philip Reilly
Nature|June 3, 2005
Stem cells: the road not takenHanno Hock, Stuart H Orkin
Nature Biotechnology|February 9, 2010
Systematic tracking of cell fate changesJonghwan Kim, Stuart H Orkin
Nature|September 28, 2007
Immunology: changed destinyHuafeng Xie, Stuart H Orkin
Current Opinion in Hematology|December 2, 2005
Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cellsHanno Hock, Stuart H Orkin
Genome Biology|September 1, 2006
Unraveling the transcriptional network controlling ES cell pluripotencySridhar Rao, Stuart H Orkin
Cell|June 14, 2011
Chromatin connections to pluripotency and cellular reprogrammingStuart H Orkin, Konrad Hochedlinger
The EMBO Journal|March 17, 2011
The erythroid/myeloid lineage fate paradigm takes a new playerJian Xu, Stuart H Orkin
Pageof 34

Showing results (11-20 of 331) with videos related to

Sort By:
Pageof 34
Genome Medicine|December 1, 2011
Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicineJonghwan Kim, Stuart H Orkin
Cell Stem Cell|January 9, 2009
Glimpses of the epigenetic landscapeXiaohua Shen, Stuart H Orkin
Science (New York, N.Y.)|May 28, 2016
MEDICINE. Paying for future success in gene therapyStuart H Orkin, Philip Reilly
Nature|June 3, 2005
Stem cells: the road not takenHanno Hock, Stuart H Orkin
Nature Biotechnology|February 9, 2010
Systematic tracking of cell fate changesJonghwan Kim, Stuart H Orkin
Nature|September 28, 2007
Immunology: changed destinyHuafeng Xie, Stuart H Orkin
Current Opinion in Hematology|December 2, 2005
Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cellsHanno Hock, Stuart H Orkin
Genome Biology|September 1, 2006
Unraveling the transcriptional network controlling ES cell pluripotencySridhar Rao, Stuart H Orkin
Cell|June 14, 2011
Chromatin connections to pluripotency and cellular reprogrammingStuart H Orkin, Konrad Hochedlinger
The EMBO Journal|March 17, 2011
The erythroid/myeloid lineage fate paradigm takes a new playerJian Xu, Stuart H Orkin
Pageof 34